Skip to content
10-Q

Quarterly Report

Revium Rx. RVRC

0001213900-26-056600

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 13, 2026 60.73M sh
Shares Diluted Q1 2026 · Mar 31, 2026 60.73M sh
Shares Diluted Q1 2026 · Mar 31, 2025 60.73M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$541K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$357K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $920K
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.68M
Stockholders Equity Q1 2026 · Mar 31, 2026 $6.16M
Stockholders Equity Q1 2026 · Dec 31, 2025 $6.88M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.53M
Current Liabilities Q1 2026 · Dec 31, 2025 $1.37M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.6M
Total Liabilities Q1 2026 · Dec 31, 2025 $1.42M
Current Assets Q1 2026 · Mar 31, 2026 $2.48M
Current Assets Q1 2026 · Dec 31, 2025 $3.1M
Total Assets Q1 2026 · Mar 31, 2026 $7.76M
Total Assets Q1 2026 · Dec 31, 2025 $8.3M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.01
Eps Diluted Q1 2026 · Mar 31, 2025 $0.01
Eps Basic Q1 2026 · Mar 31, 2026 $0.01
Eps Basic Q1 2026 · Mar 31, 2025 $0.01
Sga Expense Q1 2026 · Mar 31, 2026 $266K
Sga Expense Q1 2026 · Mar 31, 2025 $519K
Rd Expense Q1 2026 · Mar 31, 2026 $473K
Rd Expense Q1 2026 · Mar 31, 2025 $218K
Net Income Q1 2026 · Mar 31, 2026 −$725K
Net Income Q1 2026 · Mar 31, 2025 −$634K
Operating Income Q1 2026 · Mar 31, 2026 −$739K
Operating Income Q1 2026 · Mar 31, 2025 −$737K